Loan & DebtMar 29, 2026, 08:06 PM
AbbVie Announces $8.0 Billion Senior Notes Offering
AI Summary
AbbVie has entered into an underwriting agreement to issue and sell $8.0 billion in aggregate principal amount of senior notes due between 2028 and 2066. The offering includes floating rate notes and fixed-rate notes with varying interest rates, with the proceeds likely used for general corporate purposes, including debt refinancing or acquisitions.
Key Highlights
- AbbVie is issuing $750 million in floating rate notes due 2028.
- The company is issuing $7.25 billion in fixed-rate senior notes due between 2028 and 2066 with interest rates ranging from 3.775% to 5.650%.
- The notes were offered to the public at prices ranging from 99.736% to 100.000% of the principal amount.
Price Impact
More from ABBV